Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Research About the Therapeutic Effect and Safety of 10 Days Regimen With Single-agent of Decitabine for Elderly AML Patients

NCT01633099 is registered in ClinicalTrials.gov with Jianxiang Wang as lead sponsor.

NCT NCT01633099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01633099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Research About the Therapeutic Effect and Safety of 10 Days Regimen With Single-agent of Decitabine for Elderly AML Patients
Lead sponsor
Jianxiang Wang
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2012
Completion date
July 31, 2016
Enrollment
46 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug safety, effect of drugs, untreated adult acute myeloid leukemia